Topics
Glioblastoma | Treatment | Clinical trials | Ketogenic metabolic therapy
Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials > Ketogenic metabolic therapy
Amaral LJ, Gresham G, Kim S, Tighiouart M, Nelson TA, Welborn A,
Lockshon L, Noorvash B, Rudnick JD, Irwin SA, Freedland SJ, Hu J.
A phase 1 safety and feasibility trial
of a ketogenic diet plus standard of care for patients with
recently diagnosed glioblastoma.
Sci
Rep. 2025 Jul 1;15(1):21064. doi:
10.1038/s41598-025-06675-6. PMID:
40595067. Interventional study.
ˍ
ClinicalTrials.gov
ID: NCT03451799.
McKerill E, Tan JK, Rao CK, Linares CA, Banerjee S, Rabbani RD,
Adeleke S, Ghose A, Boussios S.
Efficacy
of ketogenic metabolic therapy as an adjuvant to the current
standard of care in the treatment of glioblastoma: A systematic
review of clinical trials.
Med
Oncol. 2025 Dec 11;43(1):49. doi:
10.1007/s12032-025-03165-7. PMID:
41379280. Review. ˍ
Phillips MCL, Thotathil Z, Haji Mohd Yasin NAB, de Groot C, Tan A,
Kuper-Hommel M, Creagh LA, Ji E, Naidoo N, van Essen M, Ziad F,
Moon BG, Frampton C, Jameson MB.
Intensive
multimodal ketogenic metabolic therapy in glioblastoma: A clinical
trial.
Neurooncol
Adv. 2026 Jun 29;8(1):vdag165. doi:
10.1093/noajnl/vdag165. PMID:
42542667. Trial
registration ID: NCT04730869.
ˍ